CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs – GlobeNewswire (press release)
|
CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, MA., April 04, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced the appointment of Steve … |
